VHL UK Ireland has granted £35,000 to Professor William Drake Consultant Physician/Professor of Clinical Endocrinology at St Bartholomew’s Hospital.
An overview from Professor Drake:
“Our research endeavours focus on the intricate understanding and treatment of von Hippel-Lindau (VHL) disease. We’re diligently amassing patient-specific specimens, notably tissue fragments that retain the tumour microenvironment’s vital characteristics. These fragments are pivotal in replicating the disease’s complexity. Our objective is to delve into the molecular mechanisms involved when VHL patients undergo Belzutifan therapy. By scrutinizing how Belzutifan functions across diverse tissues affected by VHL, we aspire to personalize treatment approaches and potentially influence therapeutic strategies for related conditions like renal cell carcinoma. We’re deeply appreciative of the generous support from VHL UK/Ireland, and this research holds immense promise for revolutionizing VHL disease treatment at a molecular level.”
